NI company Eolas Medical have raised a $12M Series A, led by Munich based Acton Capital with investment from Whiterock Portfolio Ventures, ScaleX Investments , Kindred Capital VC, Samaipata, and Ascension , whose renewed commitment reflects strong confidence in the company’s mission, momentum, and unique approach to reinventing how clinicians access medical knowledge.
Eolas Medical exists to solve a problem every clinician knows too well. Despite making billions of medical decisions every day, healthcare professionals still struggle to access the right context specific clinical knowledge at the point of care. Guidelines, protocols, and policies are fragmented across PDFs, intranets, and shared drives. The result is delay, inconsistency, inefficiency, frustration, and unnecessary risk.
Today, Eolas Medical supports clinicians in more than 500 healthcare sites globally, including over 85 percent of acute NHS hospitals, over 40 percent of doctors in Ireland, and leading US health systems such as Stanford Healthcare and Massachusetts General Hospital. Clinicians tell us the platform can reduce up to 90 percent of the time spent searching for clinical knowledge, improving safety, efficiency, and adherence to best practice.
The funding will allow Eolas to accelerate there AI powered clinical knowledge platform, expand across the US, Europe, and beyond, and continue building world class clinical, engineering, and commercial teams.
